• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝门部胆管癌的外科治疗]

[Surgical treatment of hilar bile duct carcinoma].

作者信息

Huang Z Q

机构信息

General Hospital of PLA, Beijing.

出版信息

Zhonghua Wai Ke Za Zhi. 1990 Sep;28(9):522-6, 572.

PMID:2086122
Abstract

Carcinoma of the bile duct at the hepatic hilar region is not a rare condition but with a low resectability rate. The incidence of this disease seems to be on increasing. In a previous report, 60 cases were explored surgically from 1975 to 1985, but resection was only possible in 5 cases (9.1%); while in the recent years from June, 1986 to June 1989, 24 cases were explored in the Surgical Department of General Hospital of PLA, 16 cases were resected, with a resectability rate of 66%. The increase of resectability rate was due to earlier recognition of this condition and the extension of surgery, including major resection of liver as well as radical dissection of the hepato-duodenal ligament and reparative operations on the blood vessels. Among these 16 cases, major hepatic resection was performed in 10 cases, in which, 3 cases of resections of the middle lobe of the liver were done instead of right or extended right lobectomy. No operative mortality in the 30 days' postoperative period, but the postoperative morbidity rate was still high and most of the complications were related to biliary leakage and infect ion. Three patients died in the postoperative follow up period at 6.14 and 15 months respectively. All of them died from biliary infection. The remaining 13 patients were still living, the longest being 40 months and the average living time was 16.1 months. Probably, lowering of the operative mortality rate and morbidity rate are still the most important considerations in the surgical treatment of hilar carcinoma at the present time.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

肝门部胆管癌并非罕见疾病,但可切除率较低。该病的发病率似乎呈上升趋势。在之前的一份报告中,1975年至1985年期间对60例患者进行了手术探查,但仅5例(9.1%)可行切除;而近年来,从1986年6月至1989年6月,解放军总医院外科对24例患者进行了探查,16例得以切除,可切除率为66%。可切除率的提高归因于对该疾病的早期诊断以及手术范围的扩大,包括肝大部切除、肝十二指肠韧带根治性清扫以及血管修复手术。在这16例患者中,10例行肝大部切除,其中3例为肝中叶切除而非右叶或扩大右叶切除。术后30天内无手术死亡,但术后发病率仍然较高,且大多数并发症与胆漏和感染有关。3例患者在术后随访期分别于6个月、14个月和15个月死亡。他们均死于胆道感染。其余13例患者仍存活,最长存活时间为40个月,平均存活时间为16.1个月。目前,降低手术死亡率和发病率可能仍是肝门部胆管癌外科治疗中最重要的考量因素。(摘要截选至250词)

相似文献

1
[Surgical treatment of hilar bile duct carcinoma].[肝门部胆管癌的外科治疗]
Zhonghua Wai Ke Za Zhi. 1990 Sep;28(9):522-6, 572.
2
Surgical treatment of hilar bile duct carcinoma. Clinical and pathological studies.
Chin Med J (Engl). 1992 Aug;105(8):635-40.
3
[Partial hepatectomy with skeletonization of the hepatoduodenal ligament for hilar cholangiocarcinoma].[肝十二指肠韧带骨骼化的肝门胆管癌根治性肝切除术]
Zhonghua Wai Ke Za Zhi. 2004 Feb 22;42(4):210-2.
4
Hepatocellular carcinoma with tumor thrombi in the bile duct.肝细胞癌伴胆管内瘤栓形成。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2495-9.
5
Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.肝门部胆管癌切除术:同期肝切除可降低肝内复发率。
Ann Surg. 2008 Aug;248(2):273-9. doi: 10.1097/SLA.0b013e31817f2bfd.
6
Block resection of the hepatoduodenal ligament for carcinoma of the bile duct and gallbladder. Surgical technique and a report of 11 cases.肝十二指肠韧带整块切除治疗胆管癌和胆囊癌。手术技术及11例报告
Hepatogastroenterology. 1991 Dec;38(6):561-7.
7
Diagnostic and surgical features of Klatskin tumors.肝门部胆管癌的诊断与手术特征。
Chir Ital. 1999 Jan-Feb;51(1):1-7.
8
Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.肝门部胆管扩大切除术的手术步骤及其在肝门部胆管癌中的应用
Hepatogastroenterology. 2002 Mar-Apr;49(44):300-5.
9
[Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].[肝门部胆管癌手术后的预后因素及长期结果。单因素和多因素分析]
Chir Ital. 2004 Nov-Dec;56(6):749-59.
10
Surgical treatment of hilar carcinoma of the bile duct.
Surg Gynecol Obstet. 1986 Feb;162(2):153-8.

引用本文的文献

1
Changing trends of surgical treatment of hilar bile duct cancer: clinical and experimental perspectives.肝门部胆管癌外科治疗的变化趋势:临床与实验视角
World J Gastroenterol. 2000 Dec;6(6):777-782. doi: 10.3748/wjg.v6.i6.777.
2
New development of biliary surgery in China.中国胆道外科的新进展。
World J Gastroenterol. 2000 Apr;6(2):187-192. doi: 10.3748/wjg.v6.i2.187.